Mergers & Acquisitions Law360 provides breaking news and analysis on high-impact mergers and acquisitions and the attorneys involved. Coverage includes major deals, related litigation and enforcement actions, and policy developments that affect corporate dealmaking.

Sign up for a 7-day FREE trial today!

Latest News in Mergers & Acquisitions

• January 08, 2026

  4 Firms Steer Coincheck's $111M Acquisition Of Crypto Firm

  The Netherlands-based holding company of Japanese digital asset exchange Coincheck Group NV has inked an agreement to become the beneficial owner of nearly all shares of Canadian alternative digital asset manager 3iQ Corp. in a deal valued at $111 million. It's guided by Dutch firm De Brauw Blackstone Westbroek, Simpson Thacher & Bartlett LLP in the U.S. and Canadian firms Stikeman Elliott and Wildeboer Dellelce LLP.

• January 08, 2026

  FTC Battles Edwards On Eve Of Heart Valve Merger Deadline

  The Federal Trade Commission asked a D.C. federal judge for a last-minute extension on an order blocking Edwards Lifesciences' $945 million acquisition of JenaValve Technology Inc., fearing difficulty with unscrambling the egg if the block expires Friday, the judge rejects its merger challenge and the deal closes before the agency can appeal.

• January 08, 2026

  States Can't Block HPE Integration Amid Deal Review

  A California federal court refused Thursday to bar Hewlett Packard Enterprise from further integrating with Juniper Networks while state enforcers raise objections to a U.S. Department of Justice settlement allowing the merger to move ahead.

• January 08, 2026

  Satellite Co. Pays $175K To End FCC's Team Telecom Case

  The Federal Communications Commission has agreed in return for a $175,000 payment to end its probe into whether a Luxembourg satellite company violated a national security deal with the U.S. government.

• January 08, 2026

  2 Firms Guide Eli Lilly's $1.2B Ventyx Biosciences Acquisition

  Eli Lilly and Co. has agreed to acquire Ventyx Biosciences Inc., a San Diego-based clinical-stage biopharmaceutical company, for about $1.2 billion in cash, with Ropes & Gray LLP and Wilson Sonsini Goodrich & Rosati PC advising.

See more Mergers & Acquisitions news